We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Polish officials expect the budget for the national reimbursement
fund, the NFZ, to reach PLN1.8bn (US$542.02mn) in 2006. From January, contributors
will increase payments by 0.25%, further boosting funds beyond an expected increase
due to macroeconomic growth.
Bangladeshi officials have outlined plans to boost exports of pharmaceuticals
to emerging drug markets in North African states such as Algeria, Morocco and
Tunisia.
Valeant Pharmaceuticals announced June 22 that it has signed an agreement with
Allergan to be the exclusive distributor of Allergan's Botox product in Hungary
and Poland.
Lonza will invest 14 million Swiss francs ($11 million) at a southern England
plant to expand production capacities there, the specialty chemicals firm said
June 22.
Inex Pharmaceuticals has announced extensive management changes and
a restructuring to conserve cash and to facilitate a new strategic path to advance
its lead anticancer drug Marqibo, its other Targeted Chemotherapy cancer products
and its promising early-stage Targeted Immunotherapy pipeline.
GlaxoSmithKline and the International AIDS Vaccine Initiative agreed to work
together in an effort to develop an AIDS vaccine. In a press release, GlaxoSmithKline
said the pact will facilitate early research and development of its nonhuman
primate adenovirus vaccine vector as a component of an AIDS vaccine.
IDM (Immuno-Designed Molecules), a privately held biopharmaceutical company, the shareholders of which recently
entered into an agreement to combine with Epimmune, today announced that it
has signed an exclusive marketing agreement for Junovan (Mepact or L-MTP-PE)
in the United Kingdom and Ireland with Cambridge Laboratories, a privately owned
British pharmaceutical company.